Breaking News
Sort by:
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF
FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell […]
Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, […]
FUJIFILM Irvine Scientific Opens European Manufacturing Facility
FUJIFILM Irvine Scientific, Inc., today announced that its new manufacturing facility in Tilburg, the Netherlands is […]
FUJIFILM Irvine Scientific Begins Customer Qualification of European Manufacturing Facility
FUJIFILM Irvine Scientific, Inc., today announced that it completed construction and started the commissioning phase of its […]
- Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
- Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
- BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
- Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
- GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more